4D Molecular Therapeutics (FDMT) Interest Coverage Ratio (2020 - 2026)
4D Molecular Therapeutics' (FDMT) quarterly Interest Coverage Ratio came in at 2.81 in Q1 2026, up 92.65% year-on-year from 1.46 in Q1 2025, and down 126.78% on a QoQ basis from 10.51 in Q4 2025.
4D Molecular Therapeutics (FDMT) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
4D Molecular Therapeutics (FDMT) has 7 years of Interest Coverage Ratio data on file, last reported at 2.81 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 92.65% year-over-year to 2.81 in Q1 2026; TTM through Mar 2026 was 6.86, a 86.83% increase from a year earlier, with the FY2025 full-year figure at 1.01, up 31.39% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 2.81, down from 10.51 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for FDMT reached as high as 10.51 in Q4 2025 and fell as low as 62.35 in Q4 2024.
- Historically, Interest Coverage Ratio has averaged 13.65 across 5 years, with a median of 2.81 in 2026.
- Across the five-year window, Interest Coverage Ratio tumbled 3084.7% in 2024 and jumped 116.86% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 9.9 in 2022, then plunged by 362.62% to 45.82 in 2023, then slumped by 36.1% to 62.35 in 2024, then jumped by 116.86% to 10.51 in 2025, then tumbled by 126.78% to 2.81 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 2.81 in Q1 2026, 10.51 in Q4 2025, and 2.11 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | 4D Molecular Therapeutics | 706.51 Mn | 315.62 Mn | - | -2.81 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.81 |
| Dec 31, 2025 | 10.51 |
| Sep 30, 2025 | -2.11 |
| Jun 30, 2025 | -1.95 |
| Mar 31, 2025 | -38.30 |
| Dec 31, 2024 | -62.35 |
| Sep 30, 2024 | -1.50 |
| Jun 30, 2024 | -15.11 |
| Mar 31, 2024 | -47.67 |
| Dec 31, 2023 | -45.82 |
| Sep 30, 2023 | -0.74 |
| Jun 30, 2023 | -1.63 |
| Mar 31, 2023 | -1.50 |
| Dec 31, 2022 | -9.90 |
| Sep 30, 2022 | -1.23 |
| Jun 30, 2022 | -5.27 |
| Mar 31, 2022 | -4.60 |
| Dec 31, 2021 | -20.64 |
| Sep 30, 2021 | -0.90 |
| Jun 30, 2021 | -2.37 |